150 related articles for article (PubMed ID: 28115406)
21. Low penetrance breast cancer predisposition SNPs are site specific.
Mcinerney N; Colleran G; Rowan A; Walther A; Barclay E; Spain S; Jones AM; Tuohy S; Curran C; Miller N; Kerin M; Tomlinson I; Sawyer E
Breast Cancer Res Treat; 2009 Sep; 117(1):151-9. PubMed ID: 19005751
[TBL] [Abstract][Full Text] [Related]
22. Pleiotropic
Walsh KM; Zhang C; Calvocoressi L; Hansen HM; Berchuck A; Schildkraut JM; Bondy ML; Wrensch M; Wiemels JL; Claus EB
Neurooncol Adv; 2022; 4(1):vdac044. PubMed ID: 35702670
[TBL] [Abstract][Full Text] [Related]
23. Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk.
Chornokur G; Lin HY; Tyrer JP; Lawrenson K; Dennis J; Amankwah EK; Qu X; Tsai YY; Jim HS; Chen Z; Chen AY; Permuth-Wey J; Aben KK; Anton-Culver H; Antonenkova N; Bruinsma F; Bandera EV; Bean YT; Beckmann MW; Bisogna M; Bjorge L; Bogdanova N; Brinton LA; Brooks-Wilson A; Bunker CH; Butzow R; Campbell IG; Carty K; Chang-Claude J; Cook LS; Cramer DW; Cunningham JM; Cybulski C; Dansonka-Mieszkowska A; du Bois A; Despierre E; Dicks E; Doherty JA; Dörk T; Dürst M; Easton DF; Eccles DM; Edwards RP; Ekici AB; Fasching PA; Fridley BL; Gao YT; Gentry-Maharaj A; Giles GG; Glasspool R; Goodman MT; Gronwald J; Harrington P; Harter P; Hein A; Heitz F; Hildebrandt MA; Hillemanns P; Hogdall CK; Hogdall E; Hosono S; Jakubowska A; Jensen A; Ji BT; Karlan BY; Kelemen LE; Kellar M; Kiemeney LA; Krakstad C; Kjaer SK; Kupryjanczyk J; Lambrechts D; Lambrechts S; Le ND; Lee AW; Lele S; Leminen A; Lester J; Levine DA; Liang D; Lim BK; Lissowska J; Lu K; Lubinski J; Lundvall L; Massuger LF; Matsuo K; McGuire V; McLaughlin JR; McNeish I; Menon U; Milne RL; Modugno F; Moysich KB; Ness RB; Nevanlinna H; Eilber U; Odunsi K; Olson SH; Orlow I; Orsulic S; Weber RP; Paul J; Pearce CL; Pejovic T; Pelttari LM; Pike MC; Poole EM; Risch HA; Rosen B; Rossing MA; Rothstein JH; Rudolph A; Runnebaum IB; Rzepecka IK; Salvesen HB; Schernhammer E; Schwaab I; Shu XO; Shvetsov YB; Siddiqui N; Sieh W; Song H; Southey MC; Spiewankiewicz B; Sucheston L; Teo SH; Terry KL; Thompson PJ; Thomsen L; Tangen IL; Tworoger SS; van Altena AM; Vierkant RA; Vergote I; Walsh CS; Wang-Gohrke S; Wentzensen N; Whittemore AS; Wicklund KG; Wilkens LR; Wu AH; Wu X; Woo YL; Yang H; Zheng W; Ziogas A; Hasmad HN; Berchuck A; ; ; Iversen ES; Schildkraut JM; Ramus SJ; Goode EL; Monteiro AN; Gayther SA; Narod SA; Pharoah PD; Sellers TA; Phelan CM
PLoS One; 2015; 10(6):e0128106. PubMed ID: 26091520
[TBL] [Abstract][Full Text] [Related]
24. Genetic variants in the mTOR pathway and breast cancer risk in African American women.
Cheng TD; Ambrosone CB; Hong CC; Lunetta KL; Liu S; Hu Q; Yao S; Sucheston-Campbell L; Bandera EV; Ruiz-Narváez EA; Haddad S; Troester MA; Haiman CA; Bensen JT; Olshan AF; Palmer JR; Rosenberg L
Carcinogenesis; 2016 Jan; 37(1):49-55. PubMed ID: 26577839
[TBL] [Abstract][Full Text] [Related]
25. [Current clinical issues and recent trends in hereditary breast and ovarian cancer in Japan-genetic testing for HBOC and risk-reducing surgery].
Arai M; Iwase T; Takazawa Y; Takeshima N
Gan To Kagaku Ryoho; 2014 Nov; 41(11):1333-9. PubMed ID: 25434434
[TBL] [Abstract][Full Text] [Related]
26. ARLTS1 germline variants and the risk for breast, prostate, and colorectal cancer.
Siltanen S; Syrjäkoski K; Fagerholm R; Ikonen T; Lipman P; Mallott J; Holli K; Tammela TL; Järvinen HJ; Mecklin JP; Aittomäki K; Blomqvist C; Bailey-Wilson JE; Nevanlinna H; Aaltonen LA; Schleutker J; Vahteristo P
Eur J Hum Genet; 2008 Aug; 16(8):983-91. PubMed ID: 18337727
[TBL] [Abstract][Full Text] [Related]
27. A genome-wide "pleiotropy scan" does not identify new susceptibility loci for estrogen receptor negative breast cancer.
Campa D; Barrdahl M; Tsilidis KK; Severi G; Diver WR; Siddiq A; Chanock S; Hoover RN; Ziegler RG; Berg CD; Buys SS; Haiman CA; Henderson BE; Schumacher FR; Le Marchand L; Flesch-Janys D; Lindström S; Hunter DJ; Hankinson SE; Willett WC; Kraft P; Cox DG; Khaw KT; Tjønneland A; Dossus L; Trichopoulos D; Panico S; van Gils CH; Weiderpass E; Barricarte A; Sund M; Gaudet MM; Giles G; Southey M; Baglietto L; Chang-Claude J; Kaaks R; Canzian F
PLoS One; 2014; 9(2):e85955. PubMed ID: 24523857
[TBL] [Abstract][Full Text] [Related]
28. Smoking, alcohol consumption, and cancer: A mendelian randomisation study in UK Biobank and international genetic consortia participants.
Larsson SC; Carter P; Kar S; Vithayathil M; Mason AM; Michaëlsson K; Burgess S
PLoS Med; 2020 Jul; 17(7):e1003178. PubMed ID: 32701947
[TBL] [Abstract][Full Text] [Related]
29. Rare Variation in TET2 Is Associated with Clinically Relevant Prostate Carcinoma in African Americans.
Koboldt DC; Kanchi KL; Gui B; Larson DE; Fulton RS; Isaacs WB; Kraja A; Borecki IB; Jia L; Wilson RK; Mardis ER; Kibel AS
Cancer Epidemiol Biomarkers Prev; 2016 Nov; 25(11):1456-1463. PubMed ID: 27486019
[TBL] [Abstract][Full Text] [Related]
30. Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium.
Campa D; Kaaks R; Le Marchand L; Haiman CA; Travis RC; Berg CD; Buring JE; Chanock SJ; Diver WR; Dostal L; Fournier A; Hankinson SE; Henderson BE; Hoover RN; Isaacs C; Johansson M; Kolonel LN; Kraft P; Lee IM; McCarty CA; Overvad K; Panico S; Peeters PH; Riboli E; Sanchez MJ; Schumacher FR; Skeie G; Stram DO; Thun MJ; Trichopoulos D; Zhang S; Ziegler RG; Hunter DJ; Lindström S; Canzian F
J Natl Cancer Inst; 2011 Aug; 103(16):1252-63. PubMed ID: 21791674
[TBL] [Abstract][Full Text] [Related]
31. Cumulative evidence of relationships between multiple variants in 8q24 region and cancer incidence.
Tong Y; Tang Y; Li S; Zhao F; Ying J; Qu Y; Niu X; Mu D
Medicine (Baltimore); 2020 Jun; 99(26):e20716. PubMed ID: 32590746
[TBL] [Abstract][Full Text] [Related]
32. Genetic variation of clock genes and cancer risk: a field synopsis and meta-analysis.
Benna C; Helfrich-Förster C; Rajendran S; Monticelli H; Pilati P; Nitti D; Mocellin S
Oncotarget; 2017 Apr; 8(14):23978-23995. PubMed ID: 28177907
[TBL] [Abstract][Full Text] [Related]
33. Early Epigenetic Markers for Precision Medicine.
Dumitrescu RG
Methods Mol Biol; 2018; 1856():3-17. PubMed ID: 30178243
[TBL] [Abstract][Full Text] [Related]
34. A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer.
Lee AW; Bomkamp A; Bandera EV; Jensen A; Ramus SJ; Goodman MT; Rossing MA; Modugno F; Moysich KB; Chang-Claude J; Rudolph A; Gentry-Maharaj A; Terry KL; Gayther SA; Cramer DW; Doherty JA; Schildkraut JM; Kjaer SK; Ness RB; Menon U; Berchuck A; Mukherjee B; Roman L; Pharoah PD; Chenevix-Trench G; Olson S; Hogdall E; Wu AH; Pike MC; Stram DO; Pearce CL;
Int J Cancer; 2016 Dec; 139(12):2646-2654. PubMed ID: 27420401
[TBL] [Abstract][Full Text] [Related]
35. Genetic variants in telomere-maintenance genes are associated with ovarian cancer risk and outcome.
Sun Y; Tao W; Huang M; Wu X; Gu J
J Cell Mol Med; 2017 Mar; 21(3):510-518. PubMed ID: 28233473
[TBL] [Abstract][Full Text] [Related]
36. Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis.
Pearce CL; Wu AH; Gayther SA; Bale AE; ; Beck PA; Beesley J; Chanock S; Cramer DW; DiCioccio R; Edwards R; Fredericksen ZS; Garcia-Closas M; Goode EL; Green AC; Hartmann LC; Hogdall E; Kjaer SK; Lissowska J; McGuire V; Modugno F; Moysich K; Ness RB; Ramus SJ; Risch HA; Sellers TA; Song H; Stram DO; Terry KL; Webb PM; Whiteman DC; Whittemore AS; Zheng W; Pharoah PD; Chenevix-Trench G; Pike MC; Schildkraut J; Berchuck A;
Br J Cancer; 2008 Jan; 98(2):282-8. PubMed ID: 18219286
[TBL] [Abstract][Full Text] [Related]
37. Selenium- or Vitamin E-Related Gene Variants, Interaction with Supplementation, and Risk of High-Grade Prostate Cancer in SELECT.
Chan JM; Darke AK; Penney KL; Tangen CM; Goodman PJ; Lee GM; Sun T; Peisch S; Tinianow AM; Rae JM; Klein EA; Thompson IM; Kantoff PW; Mucci LA
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1050-1058. PubMed ID: 27197287
[TBL] [Abstract][Full Text] [Related]
38. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
Sun J; Wiklund F; Zheng SL; Chang B; Bälter K; Li L; Johansson JE; Li G; Adami HO; Liu W; Tolin A; Turner AR; Meyers DA; Isaacs WB; Xu J; Grönberg H
J Natl Cancer Inst; 2005 Apr; 97(7):525-32. PubMed ID: 15812078
[TBL] [Abstract][Full Text] [Related]
39. Association between Adult Height and Risk of Colorectal, Lung, and Prostate Cancer: Results from Meta-analyses of Prospective Studies and Mendelian Randomization Analyses.
Khankari NK; Shu XO; Wen W; Kraft P; Lindström S; Peters U; Schildkraut J; Schumacher F; Bofetta P; Risch A; Bickeböller H; Amos CI; Easton D; Eeles RA; Gruber SB; Haiman CA; Hunter DJ; Chanock SJ; Pierce BL; Zheng W; ; ; ;
PLoS Med; 2016 Sep; 13(9):e1002118. PubMed ID: 27598322
[TBL] [Abstract][Full Text] [Related]
40. Serum perfluorooctane sulfonate and perfluorooctanoate and risk of postmenopausal breast cancer according to hormone receptor status: An analysis in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
Chang VC; Rhee J; Berndt SI; Moore SC; Freedman ND; Jones RR; Silverman DT; Gierach GL; Hofmann JN; Purdue MP
Int J Cancer; 2023 Aug; 153(4):775-782. PubMed ID: 36843273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
